Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
editorial
. 1980 Jul 26;281(6235):258–259.

Chronic active hepatitis.

PMCID: PMC1713784  PMID: 7427234

Full text

PDF
258

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter H. J. The dominant role of non-A, non-B in the pathogenesis of post-transfusion hepatitis: a clinical assessment. Clin Gastroenterol. 1980 Jan;9(1):155–170. [PubMed] [Google Scholar]
  2. Anthony P. P., Ishak K. G., Nayak N. C., Poulsen H. E., Scheuer P. J., Sobin L. H. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol. 1978 May;31(5):395–414. doi: 10.1136/jcp.31.5.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berman M., Alter H. J., Ishak K. G., Purcell R. H., Jones E. A. The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med. 1979 Jul;91(1):1–6. doi: 10.7326/0003-4819-91-1-1. [DOI] [PubMed] [Google Scholar]
  4. Black M., Rabin L., Schatz N. Nitrofurantoin-induced chronic active hepatitis. Ann Intern Med. 1980 Jan;92(1):62–64. doi: 10.7326/0003-4819-92-1-62. [DOI] [PubMed] [Google Scholar]
  5. Cook G. C., Mulligan R., Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971 Apr;40(158):159–185. doi: 10.1093/oxfordjournals.qjmed.a067264. [DOI] [PubMed] [Google Scholar]
  6. De Groote J., Fevery J., Lepoutre L. Long-term follow-up of chronic active hepatitis of moderate severity. Gut. 1978 Jun;19(6):510–513. doi: 10.1136/gut.19.6.510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dudley F. J., Scheuer P. J., Sherlock S. Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet. 1972 Dec 30;2(7792):1388–1393. doi: 10.1016/s0140-6736(72)92963-7. [DOI] [PubMed] [Google Scholar]
  8. Ellis W. R., Murray-Lyon I. M., Coleman J. C., Evans B. A., Fluker J. L., Bull J., Keeling P. W., Simmons P. D., Banatvala J. E., Willcox J. R. Liver disease among homosexual males. Lancet. 1979 Apr 28;1(8122):903–905. doi: 10.1016/s0140-6736(79)91376-x. [DOI] [PubMed] [Google Scholar]
  9. Geubel A. P., Baggenstoss A. H., Summerskill W. H. Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome. Gastroenterology. 1976 Sep;71(3):444–449. [PubMed] [Google Scholar]
  10. Goldberg S. J., Mendenhall C. L., Connell A. M., Chedid A. "Nonalcoholic" chronic hepatitis in the alcoholic. Gastroenterology. 1977 Apr;72(4 Pt 1):598–604. [PubMed] [Google Scholar]
  11. Golding P. L., Smith M., Williams R. Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am J Med. 1973 Dec;55(6):772–782. doi: 10.1016/0002-9343(73)90258-1. [DOI] [PubMed] [Google Scholar]
  12. Kirk A. P., Jain S., Pocock S., Thomas H. C., Sherlock S. Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. Gut. 1980 Jan;21(1):78–83. doi: 10.1136/gut.21.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Knodell R. G., Conrad M. E., Ishak K. G. Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention. Gastroenterology. 1977 May;72(5 Pt 1):902–909. [PubMed] [Google Scholar]
  14. Maddrey W. C., Boitnott J. K. Drug-induced chronic liver disease. Gastroenterology. 1977 Jun;72(6):1348–1353. [PubMed] [Google Scholar]
  15. Murray-Lyon I. M., Stern R. B., Williams R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet. 1973 Apr 7;1(7806):735–737. doi: 10.1016/s0140-6736(73)92125-9. [DOI] [PubMed] [Google Scholar]
  16. Scott J., Gollan J. L., Samourian S., Sherlock S. Wilson's disease, presenting as chronic active hepatitis. Gastroenterology. 1978 Apr;74(4):645–651. [PubMed] [Google Scholar]
  17. Sharp J. R., Ishak K. G., Zimmerman H. J. Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin. Ann Intern Med. 1980 Jan;92(1):14–19. doi: 10.7326/0003-4819-92-1-14. [DOI] [PubMed] [Google Scholar]
  18. Summerskill W. H., Korman M. G., Ammon H. V., Baggenstoss A. H. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut. 1975 Nov;16(11):876–883. doi: 10.1136/gut.16.11.876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Thomas F. B. Chronic aggressive hepatitis induced by halothane. Ann Intern Med. 1974 Oct;81(4):487–489. doi: 10.7326/0003-4819-81-4-487. [DOI] [PubMed] [Google Scholar]
  20. Utili R., Boitnott J. K., Zimmerman H. J. Dantrolene-associated hepatic injury. Incidence and character. Gastroenterology. 1977 Apr;72(4 Pt 1):610–616. [PubMed] [Google Scholar]
  21. Williams R., Eddleston A. L. Chronic active hepatitis: immunopathogenesis and immunotherapy. Isr J Med Sci. 1979 Mar;15(3):261–275. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES